↓ Skip to main content

mRNA therapy for myocardial infarction: A review of targets and delivery vehicles

Overview of attention for article published in Frontiers in Bioengineering and Biotechnology, November 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

twitter
5 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
mRNA therapy for myocardial infarction: A review of targets and delivery vehicles
Published in
Frontiers in Bioengineering and Biotechnology, November 2022
DOI 10.3389/fbioe.2022.1037051
Pubmed ID
Authors

Xinming Wang, Douglas H. Wu, Samuel E. Senyo

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 22%
Student > Bachelor 3 17%
Student > Doctoral Student 2 11%
Student > Ph. D. Student 2 11%
Unknown 7 39%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 28%
Agricultural and Biological Sciences 2 11%
Chemistry 2 11%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Engineering 1 6%
Other 0 0%
Unknown 7 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 December 2023.
All research outputs
#6,398,671
of 25,758,211 outputs
Outputs from Frontiers in Bioengineering and Biotechnology
#901
of 8,648 outputs
Outputs of similar age
#118,503
of 491,892 outputs
Outputs of similar age from Frontiers in Bioengineering and Biotechnology
#29
of 549 outputs
Altmetric has tracked 25,758,211 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,648 research outputs from this source. They receive a mean Attention Score of 3.5. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 491,892 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 549 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.